Cargando…
Successful delivery of large-size CRISPR/Cas9 vectors in hard-to-transfect human cells using small plasmids
With the rise of new powerful genome engineering technologies, such as CRISPR/Cas9, cell models can be engineered effectively to accelerate basic and disease research. The most critical step in this procedure is the efficient delivery of foreign nucleic acids into cells by cellular transfection. Sin...
Autores principales: | Søndergaard, Jonas Nørskov, Geng, Keyi, Sommerauer, Christian, Atanasoai, Ionut, Yin, Xiushan, Kutter, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305135/ https://www.ncbi.nlm.nih.gov/pubmed/32561814 http://dx.doi.org/10.1038/s42003-020-1045-7 |
Ejemplares similares
-
CCT3-LINC00326 axis regulates hepatocarcinogenic lipid metabolism
por: Søndergaard, Jonas Nørskov, et al.
Publicado: (2022) -
Target-enriched nanopore sequencing and de novo assembly reveals co-occurrences of complex on-target genomic rearrangements induced by CRISPR-Cas9 in human cells
por: Geng, Keyi, et al.
Publicado: (2022) -
CRISPR-Cas9 delivery to hard-to-transfect cells via membrane deformation
por: Han, Xin, et al.
Publicado: (2015) -
Intrinsic deletion at 10q23.31, including the PTEN gene locus, is aggravated upon CRISPR-Cas9–mediated genome engineering in HAP1 cells mimicking cancer profiles
por: Geng, Keyi, et al.
Publicado: (2023) -
Protocol for IPO11 deletion and re-expression in H460 lung cancer cells using CRISPR-Cas9 and plasmid transfection
por: Zhang, Yarui, et al.
Publicado: (2023)